Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Big pharma stocks near all-time highs as tech selloff pushes investors toward safer bets
Biopharma stocks like AbbVie and Eli Lilly are trading at or near all-time highs, in the latest signal that investors are seeking out the steady gains that come with large, diversified drugmakers. These companies are doing what they do best…
Zydus-Sunshine JV signs pact with Sri Lanka's BOI for $20 mn pharma plant
Published - October 15, 2026 07:11 pm IST - HYDERABAD Subscribe to The Hindu @ Just ₹1* Subscribe to The Hindu @ Just $4.99 *Offer only for new subscribers Zydus Sunshine Lifesciences, a proposed joint venture between Zydus Lifesciences and…
Mankind Pharma to acquire 70% stake in ACTx for €48 million
Mankind Pharma has agreed to acquire a 70% stake in Belgium-based biotechnology company Armed Cell Therapeutics (ACTx) for €48 million, marking its entry into next-generation CAR-T cancer therapies as it looks to expand its research and…
AMGN vs. MRK: Which Pharma Giant's Dividend Actually Has Room to Grow
Should an investor saving for retirement put their next dollar of income capital into Amgen (NASDAQ:AMGN | AMGN Price Prediction) or Merck (NYSE:MRK)? The two yields are near identical. Amgen's annualized forward dividend of $10.08 on a $437.04…
Troy Jackson got $15k from big oil, pharma lobbyists. He's giving it to charity.
Read all of our coverage of Maine's 2026 election or stay up to date with the latest developments through the Maine Political Report in your inbox or text messages from politics editor Kirby Wilson. Troy Jackson is donating about $15,000 in…
Zydus Sunshine to invest over $20 million in Sri Lanka pharma plant
Zydus Sunshine Lifesciences, a joint venture between Zydus Lifesciences Ltd and Sunshine Healthcare, has signed an agreement with the Board of Investment of Sri Lanka to set up a pharmaceutical manufacturing facility in the island nation, according…
Ascentage Pharma Group International - Unsponsored ADR (AAPG) - What Are Researchers Thinking About This Stock?
Shares of Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) have earned a consensus recommendation of 'Buy' from the fourteen ratings firms that are currently covering the company, MarketBeat reports. Twelve…
Agility, Access And Scale: 3 Factors Defining Biotech's Future
Brian O'Shaughnessy is Chief Commercial Officer at Uniphar. As one of the leading genetic causes of infant mortality, spinal muscular atrophy (SMA) is a devastating neuromuscular disease that progressively strips young children of the ability to…
Berlin and Paris open 'Made in Europe' door to Switzerland
Switzerland would be treated on an equal footing with the countries of the European Economic Area and the United Kingdom. This is according to a Franco-German position paper published on Thursday, a copy of which has been seen by the Keystone-SDA…
Korea's 1st homegrown obesity drug likely to intensify price competition
Korea's first homegrown obesity drug could shake up a market dominated by Mounjaro and Wegovy, an industry official said, as more Koreans travel to Japan to obtain cheaper Mounjaro and bring it home illegally, driven by the high cost of obesity…
Siemens Switzerland to build new headquarters in Zurich
The Siemens site covers an area of 30,500 square metres and comprises around 35,900 square metres of space, as Procimmo announced on Thursday. The parties have agreed not to disclose the purchase price, as a Siemens spokesperson explained in…
Zurich prosecutor charges journalist over Vincenz revelations
‘Switzerland is a partial member of the EU,' says historian Read more: ‘Switzerland is a partial member of the EU,' says historian Rising inequality, diesel deal and another execution Read more: Rising inequality, diesel deal and…
Japan's Nikkei slumps 5 percent as tech stocks hammered by AI, rate hike worries
Japan's Nikkei share average tumbled nearly 5 percent on Thursday, with tech stocks hit hard by media reports about distressed debt at US cloud-computing provider CoreWeave, while hot US inflation figures sparked fears of higher interest rates.
Erasca, Inc: The Discount RevMed? (NASDAQ:ERAS)
Erasca, Inc. is positioned as a key contender in the transformative KRAS inhibitor market, trailing Revolution Medicines but showing promising early data. ERAS-0015 demonstrates strong preliminary response rates in KRAS-mutated pancreatic and lung…
Q2 Results 16th Oct Live: DLF, LTM, Oberoi, PNB, Urban Company, Ujjivan SFB, Federal Bank to announce Q2 results, Tech Mahindra shares up 5% after Q2, Wipro up 2%, Jio, Nestle, HDFC Life, Persistent Systems in red, Cyient DLM tanks 19%
Q2 Results Today, 16th October 2026 Live Updates: Find all the latest Q2 results 2026 updates of Amal, Artson, Aurum PropTech, Bajaj Housing Finance, Benares Hotels, Bright Outdoor Media, Citi Port Financial Services, Crompton Greaves Consumer…
Receive a Daily briefing on Pharma Industry News
Get Started